Ajay holds a bachelor’s degree in business administration from European University of Brussels, Belgium. Sahni has over 36 years of experience in FMCG & pharmaceutical industries. His expertise spans financial management, business development and general management.

Ajay in his previous leadership roles, was the managing director for Pinewood Healthcare, Ireland; managing director for Wockhardt Bio AG, Switzerland; president of Wockhardt France SAS and its subsidiaries.

He has a vast experience performing all kinds of roles including finance director, project manager- business development, director (financial control, planning and analysis), regional finance director for South and South-East Asia, president, and managing director in various companies viz., Sanofi SA, SanofiSynthelabo Inc., Sanofi-Synthelabo Pte., Ferring Pharmaceuticals, Wockhardt France SAS and multiple subsidiaries including Laboratoires Negma SAS, Wockhardt Bio AG. and Pinewood Healthcare.

Gland Pharma is a Hyderabad-based pharmaceutical company focused on generic injectables and ophthalmics. It operates in more than 60 countries under a business-to-business model and offers a broad portfolio of sterile injectable products, including vials, ampoules, pre-filled syringes, lyophilized vials, infusions, oncology and ophthalmic solutions.

The company’s consolidated net profit jumped 47.09% to Rs 316.96 crore in Q1 FY27 compared with Rs 215.48 crore in Q1 FY26. Revenue from operations climbed 19.57% YoY to Rs 1,800.27 crore in Q1 FY27.

The scrip 0.74% to settled at Rs 3097.50 on the BSE.